SPARK Microgravity

SPARK Microgravity builds autonomous orbital research laboratories for cancer research, enabling pharmaceutical companies and scientists to study cancer biology and drug response in microgravity to improve preclinical data before clinical trials. The company will help translate space-based biological insights into more predictive research, better therapeutic decisions, and ultimately improved treatment options for cancer patients on Earth.